Radiation-induced astrocyte senescence is rescued by Δ133p53.
IL-6
astrocytes
p53 isoform
radiation-induced brain injury
senescence
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
18 03 2019
18 03 2019
Historique:
pubmed:
8
1
2019
medline:
28
4
2020
entrez:
8
1
2019
Statut:
ppublish
Résumé
Cellular senescence and the senescence-associated secretory phenotype (SASP) may contribute to the development of radiation therapy-associated side effects in the lung and blood vessels by promoting chronic inflammation. In the brain, inflammation contributes to the development of neurologic disease, including Alzheimer's disease. In this study, we investigated the roles of cellular senescence and Δ133p53, an inhibitory isoform of p53, in radiation-induced brain injury. Senescent cell types in irradiated human brain were identified with immunohistochemical labeling of senescence-associated proteins p16INK4A and heterochromatin protein Hp1γ in 13 patient cases, including 7 irradiated samples. To investigate the impact of radiation on astrocytes specifically, primary human astrocytes were irradiated and examined for expression of Δ133p53 and induction of SASP. Lentiviral expression of ∆133p53 was performed to investigate its role in regulating radiation-induced cellular senescence and astrocyte-mediated neuroinflammation. Astrocytes expressing p16INK4A and Hp1γ were identified in all irradiated tissues, were increased in number in irradiated compared with untreated cancer patient tissues, and had higher labeling intensity in irradiated tissues compared with age-matched controls. Human astrocytes irradiated in vitro also experience induction of cellular senescence, have diminished Δ133p53, and adopt a neurotoxic phenotype as demonstrated by increased senescence-associated beta-galactosidase activity, p16INK4A, and interleukin (IL)-6. In human astrocytes, Δ133p53 inhibits radiation-induced senescence, promotes DNA double-strand break repair, and prevents astrocyte-mediated neuroinflammation and neurotoxicity. Restoring expression of the endogenous p53 isoform, ∆133p53, protects astrocytes from radiation-induced senescence, promotes DNA repair, and inhibits astrocyte-mediated neuroinflammation.
Sections du résumé
BACKGROUND
Cellular senescence and the senescence-associated secretory phenotype (SASP) may contribute to the development of radiation therapy-associated side effects in the lung and blood vessels by promoting chronic inflammation. In the brain, inflammation contributes to the development of neurologic disease, including Alzheimer's disease. In this study, we investigated the roles of cellular senescence and Δ133p53, an inhibitory isoform of p53, in radiation-induced brain injury.
METHODS
Senescent cell types in irradiated human brain were identified with immunohistochemical labeling of senescence-associated proteins p16INK4A and heterochromatin protein Hp1γ in 13 patient cases, including 7 irradiated samples. To investigate the impact of radiation on astrocytes specifically, primary human astrocytes were irradiated and examined for expression of Δ133p53 and induction of SASP. Lentiviral expression of ∆133p53 was performed to investigate its role in regulating radiation-induced cellular senescence and astrocyte-mediated neuroinflammation.
RESULTS
Astrocytes expressing p16INK4A and Hp1γ were identified in all irradiated tissues, were increased in number in irradiated compared with untreated cancer patient tissues, and had higher labeling intensity in irradiated tissues compared with age-matched controls. Human astrocytes irradiated in vitro also experience induction of cellular senescence, have diminished Δ133p53, and adopt a neurotoxic phenotype as demonstrated by increased senescence-associated beta-galactosidase activity, p16INK4A, and interleukin (IL)-6. In human astrocytes, Δ133p53 inhibits radiation-induced senescence, promotes DNA double-strand break repair, and prevents astrocyte-mediated neuroinflammation and neurotoxicity.
CONCLUSIONS
Restoring expression of the endogenous p53 isoform, ∆133p53, protects astrocytes from radiation-induced senescence, promotes DNA repair, and inhibits astrocyte-mediated neuroinflammation.
Identifiants
pubmed: 30615147
pii: 5273763
doi: 10.1093/neuonc/noz001
pmc: PMC6422440
doi:
Substances chimiques
Protein Isoforms
0
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
474-485Informations de copyright
Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2019.
Références
Cancer Res. 2003 Jul 15;63(14):4021-7
pubmed: 12874001
Radiat Res. 2016 Aug;186(2):153-61
pubmed: 27387862
Mol Neurobiol. 2017 Mar;54(2):1022-1032
pubmed: 26797684
Acta Oncol. 2002;41(4):346-51
pubmed: 12234025
Cell Tissue Res. 2015 Jan;359(1):279-94
pubmed: 25227552
PLoS One. 2012;7(9):e44156
pubmed: 22970173
Physiol Rev. 2014 Oct;94(4):1077-98
pubmed: 25287860
Front Oncol. 2012 Jul 19;2:73
pubmed: 22833841
Aging Cell. 2008 Oct;7(5):630-40
pubmed: 18616637
J Clin Oncol. 1992 Sep;10(9):1390-6
pubmed: 1517781
J Child Neurol. 2016 Mar;31(4):488-505
pubmed: 26245798
Neurosurg Focus. 1998 Apr 15;4(4):e5
pubmed: 17168505
Annu Rev Physiol. 2013;75:685-705
pubmed: 23140366
Cancer Discov. 2017 Feb;7(2):165-176
pubmed: 27979832
Cell Prolif. 1991 Sep;24(5):481-91
pubmed: 1932357
Int J Cancer. 2012 Apr 15;130(8):1715-25
pubmed: 22025288
Tumour Biol. 2010 Aug;31(4):363-72
pubmed: 20490962
Cell Death Differ. 2016 Sep 1;23(9):1515-28
pubmed: 27104929
Oncol Rep. 1998 May-Jun;5(3):679-83
pubmed: 9538175
J Med Primatol. 2001 Apr;30(2):81-7
pubmed: 11491408
Mol Gen Genet. 1996 Apr 24;251(1):1-12
pubmed: 8628240
Cancer Res. 2016 Mar 1;76(5):1170-80
pubmed: 26759233
Aging (Albany NY). 2013 Aug;5(8):607-22
pubmed: 23928451
PLoS One. 2013 Jun 27;8(6):e67204
pubmed: 23826235
Exp Neurol. 2004 Aug;188(2):316-30
pubmed: 15246832
J Natl Cancer Inst. 2013 Oct 2;105(19):1474-84
pubmed: 24052614
J Alzheimers Dis. 2009;18(3):473-81
pubmed: 19584454
Front Aging Neurosci. 2016 Aug 31;8:208
pubmed: 27630559
J Clin Oncol. 2014 Dec 1;32(34):3810-6
pubmed: 25349290
Int J Radiat Biol. 2015 Mar;91(3):224-39
pubmed: 25426696
Cell Death Differ. 2017 Jun;24(6):1017-1028
pubmed: 28362428
Neuro Oncol. 2013 Mar;15(3):360-9
pubmed: 23322748
Eur J Neurosci. 2011 Jul;34(1):3-11
pubmed: 21649759
J Int Neuropsychol Soc. 2015 Oct;21(9):657-69
pubmed: 26391667
Int J Radiat Biol. 2010 Feb;86(2):132-44
pubmed: 20148699
J Clin Invest. 2018 Apr 2;128(4):1208-1216
pubmed: 29457783
Cancer. 2017 Jan 1;123(1):161-168
pubmed: 27571577
Exp Neurol. 1997 Oct;147(2):418-27
pubmed: 9344566
Science. 2003 Dec 5;302(5651):1760-5
pubmed: 14615545
Stem Cell Reports. 2017 Oct 10;9(4):1221-1233
pubmed: 28966121
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Neurosci Lett. 1995 Dec 29;202(1-2):17-20
pubmed: 8787820
Biotechniques. 2001 Jun;30(6):1322-6, 1328, 1330-1
pubmed: 11414226
Nat Cell Biol. 2009 Sep;11(9):1135-42
pubmed: 19701195
Oncogene. 2018 May;37(18):2379-2393
pubmed: 29429991
Front Immunol. 2017 May 05;8:517
pubmed: 28529513
J Neurooncol. 2005 May;72(3):245-53
pubmed: 15937648
JAMA. 1998 Nov 4;280(17):1485-9
pubmed: 9809728
Genes Dev. 2010 Nov 15;24(22):2463-79
pubmed: 21078816
J Clin Invest. 2018 Apr 2;128(4):1238-1246
pubmed: 29608137
J Neurosci Res. 2014 Jul;92(7):915-26
pubmed: 24936619
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210
Lancet. 2009 Nov 7;374(9701):1639-51
pubmed: 19897130
Nat Med. 2002 Sep;8(9):955-62
pubmed: 12161748
Oncology (Williston Park). 2017 Mar 15;31(3):182-8
pubmed: 28299754
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567